SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清零JH
Lv4
720 积分
2021-08-30 加入
最近求助
最近应助
互助留言
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors
10个月前
已完结
Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0/A hepatocellular carcinoma: A large-scale multicenter study
1年前
已完结
Impact of tumor burden score on timing and patterns of recurrence after curative-intent resection of hepatocellular carcinoma
1年前
已完结
Identification of Risk Factors and Phenotypes of Surgical Site Infection in Patients After Abdominal Surgery
1年前
已完结
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
1年前
已完结
A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria
1年前
已完结
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis
1年前
已完结
Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
1年前
已完结
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study
1年前
已完结
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria
1年前
已完结
没有进行任何应助
点赞
2年前
点赞
2年前
感谢
2年前
感谢
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论